Johnson & Johnson boosts full-year guidance

Johnson & Johnson has lifted its full-year forecast by reporting adjusted earnings and revenues on Tuesday that exceeded Wall Street’s expectations. J&J said that its first-quarter sales increased by 5.6 percent over the same quarter last year.

The company reported a net loss of $68 million, 3 cents per share, as a result of a special one-time charge. This is compared to the same period last year with a net income of $ 5.2 billion, or $1.93 per share.

Joaquin Duato, the chairman of the Board and CEO of J&J said “our first quarter results demonstrate strong performance across all three segments of our business and reflect the dedication of Johnson & Johnson colleagues around the world,”

Duato also said that he looks forward to the remaining of the year, saying that he expects it to be “one filled with exciting catalysts that will create both near- and long-term value for patients and all of our stakeholders.”